Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kevin Kotler, Broadfin Capital Raise Holding in Derma Sciences Inc (DSCI)

Kevin Kotler‘s Broadfin Capital has increased its position in Derma Sciences Inc (NASDAQ:DSCI). According to a new filing with the SEC, Broadfin holds around 871,600 shares, up from 771,600 shares revealed in its latest 13F. The position is passive by nature and amasses 5.04% of the company’s common stock. The value of the holding amounts to some $9.6 million, at the current stock price of the company.

Kevin Kotler

Derma Sciences Inc (NASDAQ:DSCI), is a healthcare company involved in wound care. the company reported a 12% increase in net sales on the year to $22.1 million. The net loss of the company, however, expanded to $4.9 million, or $0.29 per share, from $3.1 million in the same period of last year. The stock of Derma Sciences Inc (NASDAQ:DSCI) edged down by around 0.2% since the beginning of the year.

Among the largest stockholders of Derma Sciences Inc (NASDAQ:DSCI) is Baker Bros. Advisors, led by Julian Baker and Felix Baker, which owns around 2.6 million shares, with a reported value of $31.7 million. It is followed by Peter Kolchinsky‘s Ra Capital Management, and Stephen Dubois‘ Camber Capital Management, which, in their latest 13F filings, revealed holding almost 2.0 million shares, and 950,000 shares respectively. The value of the positions amounts to $24.7 million, and $11.8 million respectively.

Among other recent moves into healthcare companies, Broadfin boosted its position in Horizon Pharma Inc (NASDAQ:HZNP) to 3.9 million shares, from 1.9 million held earlier. Currently, the fund holds 5.9% of Horizon’s common stock. The fund also added Alliqua Inc (OTCMKTS:ALQAD) to its equity portfolio, the stake comprising 774,400 shares, equal to 7.8% of the common stock.

The largest stake in the fund’s equity portfolio is represented by Depomed Inc (NASDAQ:DEPO), in which Broadfin revealed holding over 5.6 million shares, worth $42 million.

Disclosure: none

Recommended Reading:

Nokomis Capital Trims Position in DSP Group, Inc. (DSPG)

Hedge Fund News: Tiger Management, Phillip Goldstein & Michael Steinberg

Five Hedge Fund Moves in Healthcare Sector From This Week

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.